Evaluation of Rocuronium Associated to Acepromazine, Propofol and Isofluorane in the Anesthesia of Female Canines Submitted to Elective Ovaryhysterectomy

Cinthya Dessaune Neves

Authors

Cinthya Dessaune Neves

Keywords:

rocuronium, female canines, ovary hysteric tomy

Abstract

Abstract not found

Downloads

How to Cite

Evaluation of Rocuronium Associated to Acepromazine, Propofol and Isofluorane in the Anesthesia of Female Canines Submitted to Elective Ovaryhysterectomy. (2014). Global Journal of Medical Research, 14(E4), 7-12. https://medicalresearchjournal.org/index.php/GJMR/article/view/626

Download Citation

References

Maria Almeida, Giovani Locks (2011) Sugammadex®: novos questionamentos sobre a reversão. 61(6), 830-831.

L Booij (1997) Neuromuscular transmission and its pharmacological blockade. 19(1), 1-12.

S Cortopassi, D Fantoni (2002) Medicação Pré-Anestésica. 151-158.

S Dibartola (2006) Introduction to Acid-Base Disorders. 1, 229-251.

Alexandra Dugdale, Wendy Adams, Ronald Jones (2002) The clinical use of the neuromuscular blocking agent rocuronium in dogs. 29(1), 49-53.

T Duke (1995) A new intravenous anesthetic agent: Propofol. 36(3), 181-183.

A Evers, M Crowder, J Balser (2006) Anestésicos Gerais. In: Godman & Gilman As Bases Farmacológicas da Terapêutica. 11ªed. 305-329.

P Ferro, N Nunes, R Carareto, C Nishimori, D Paula, P Sousa, R Thiesen (2007) Efeitos de diferentes frações inspiradas de oxigênio sobre a dinâmica respiratória em cães submetidos à infusão contínua de propofol e mantidos em ventilação espontânea. 44, 30-37.

P Ferro, N Nunes, D Paula, C Nishimori, E Conceição, P Guerrero, L Arruda (2005) Variáveis fisiológicas em cães submetidos à 10.

R Fuller, Iii Muir (2001) Uso de los bloqueadores neuromusculares en pacientes obesos. 53(4), 149-158.

F Futema (2002) Avaliação pré-anestésica. 59-63.

L Hall (1971) Relaxation of The Skeletal Muscles During Anesthesia. 6, 385-423.

J Hunter (1996) Rocuronium: the newest aminosteroid neuromuscular blocking drug. 76(4), 481-483.

E Mccoy, R Mirakhur, V Maddineni, J Wierda, J Proost (1996) Pharmacokinetics of rocuronium after bolus and continuous infusion during halothane anaesthesia. 76(1), 29-33.

infusão contínua de diferentes doses de propofol. 35(5), 1103-1108.

L Miranda, L Barrucand, J Tsai, N Verçosa (2008) Estudo comparativo entre uma e duas doses efetivas (DE 95 ) de rocurônio para a intubação traqueal. 58(3).

C Neves (2007) Rocurônio como miorrelaxante em cirurgias ortopédicas de cães. Monografia de Especilização em Clínica e Cirurgia Veterinárias. 31.

J Proost, L Eriksson, R Mirakhur, G Roest, J Wierda (2000) Urinary, biliary and faecal excretion of rocuronium in humans. 85(5), 717-723.

Tadashi Sano, Ryohei Nishimura, Manabu Mochizuki, Yasushi Hara, Masahiro Tagawa, Nobuo Sasaki (2003) Clinical Usefulness of Propofol as an Anesthetic Induction Agent in Dogs and Cats. 65(5), 641-643.

Charles Short, Antonello Bufalari (1999) Propofol Anesthesia. 29(3), 747-778.

W Tranquili, J Thurmon, K Grimm (1096) Veterinary Anesthesia and Analgesia.

J Wierda, J Proost (1995) The pharmacokinetics and the pharmacokineticsdynamic relatioship of rocuronium bromide. 3, 192-201.

P Wright, P Hart, M Lau, M Swharma, L Gruenke, D Fisher (1994) Cumulative characteristics of atracurium and vecuronium. A simultaneous clinical and pharmacokinetic study. 81, 59-68.

F Xue, X Liao, S Tong, J Liu, G An, L Luo (1998) Dose-response and time‐course of the effect of rocuronium bromide during sevoflurane anaesthesia. 53(1), 25-30.